Clean Yield Group grew its holdings in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 16.2% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 67,341 shares of the company's stock after purchasing an additional 9,384 shares during the quarter. Clean Yield Group owned approximately 0.15% of Vital Farms worth $2,052,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. CIBC Private Wealth Group LLC grew its holdings in shares of Vital Farms by 152.1% during the fourth quarter. CIBC Private Wealth Group LLC now owns 895 shares of the company's stock valued at $35,000 after buying an additional 540 shares during the last quarter. US Bancorp DE raised its stake in shares of Vital Farms by 160.3% in the fourth quarter. US Bancorp DE now owns 1,416 shares of the company's stock worth $53,000 after purchasing an additional 872 shares during the last quarter. Frazier Financial Advisors LLC acquired a new stake in shares of Vital Farms during the fourth quarter worth about $59,000. Principal Securities Inc. boosted its position in Vital Farms by 29.4% in the fourth quarter. Principal Securities Inc. now owns 1,673 shares of the company's stock valued at $63,000 after buying an additional 380 shares during the last quarter. Finally, Rothschild Investment LLC increased its holdings in Vital Farms by 191.2% in the 4th quarter. Rothschild Investment LLC now owns 1,814 shares of the company's stock worth $68,000 after buying an additional 1,191 shares during the period. 98.59% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on VITL. BMO Capital Markets raised Vital Farms to a "strong-buy" rating in a report on Tuesday, May 6th. William Blair reaffirmed an "outperform" rating on shares of Vital Farms in a report on Friday, February 28th. DA Davidson cut their price target on Vital Farms from $44.00 to $42.00 and set a "buy" rating for the company in a research note on Friday, March 14th. Morgan Stanley cut their target price on shares of Vital Farms from $40.00 to $39.00 and set an "overweight" rating for the company in a research note on Thursday, April 17th. Finally, Stifel Nicolaus upgraded Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 target price on the stock in a research report on Friday, February 28th. Eight analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $44.63.
Read Our Latest Research Report on VITL
Vital Farms Stock Down 1.6%
Shares of NASDAQ:VITL traded down $0.53 during midday trading on Wednesday, hitting $32.13. 380,732 shares of the stock were exchanged, compared to its average volume of 1,024,687. The company has a market capitalization of $1.43 billion, a PE ratio of 28.68 and a beta of 0.89. The business's fifty day simple moving average is $33.41 and its two-hundred day simple moving average is $35.17. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24. Vital Farms, Inc. has a 52-week low of $27.91 and a 52-week high of $48.41.
Vital Farms (NASDAQ:VITL - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.26 by $0.11. The company had revenue of $162.19 million for the quarter, compared to analysts' expectations of $164.43 million. Vital Farms had a return on equity of 22.29% and a net margin of 8.68%. The business's revenue for the quarter was up 9.7% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.43 earnings per share. As a group, research analysts predict that Vital Farms, Inc. will post 1.11 earnings per share for the current fiscal year.
Insider Activity at Vital Farms
In related news, CEO Russell Diez-Canseco sold 45,124 shares of the stock in a transaction dated Monday, April 14th. The shares were sold at an average price of $33.69, for a total transaction of $1,520,227.56. Following the completion of the transaction, the chief executive officer now owns 703,736 shares in the company, valued at approximately $23,708,865.84. This represents a 6.03% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Matthew Ohayer sold 20,000 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $29.46, for a total value of $589,200.00. Following the sale, the insider now directly owns 6,970,890 shares in the company, valued at $205,362,419.40. This trade represents a 0.29% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 93,124 shares of company stock worth $3,019,308. Insiders own 21.30% of the company's stock.
Vital Farms Company Profile
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Featured Stories

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.